Reply to Decroo et al.: High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis

Detalles Bibliográficos
Autores principales: Dooley, Kelly E., Miyahara, Sachiko, von Groote-Bidlingmaier, Florian, Sun, Xin, Hafner, Richard, Rosenkranz, Susan L., Ignatius, Elisa H., Nuermberger, Eric L., Moran, Laura, Donahue, Kathleen, Swindells, Susan, Vanker, Naadira, Diacon, Andreas H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301745/
https://www.ncbi.nlm.nih.gov/pubmed/32130866
http://dx.doi.org/10.1164/rccm.202002-0359LE

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301745/
https://www.ncbi.nlm.nih.gov/pubmed/32130866
http://dx.doi.org/10.1164/rccm.202002-0359LE

Ejemplares similares